These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6578531)

  • 1. Brain purinergic activity linked with depressive symptomatology: hypoxanthine and xanthine in CSF of patients with major depressive disorders.
    Agren H; Niklasson F; Hällgren R
    Psychiatry Res; 1983 Jul; 9(3):179-89. PubMed ID: 6578531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purine and monoamine metabolites in cerebrospinal fluid: parallel purinergic and monoaminergic activation in depressive illness?
    Niklasson F; Agren H; Hällgren R
    J Neurol Neurosurg Psychiatry; 1983 Mar; 46(3):255-60. PubMed ID: 6188805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression and somatosensory evoked potentials: I. Correlations between SEP and monoamine and purine metabolites in CSF.
    Agren H; Osterberg B; Niklasson F; Franzén O
    Biol Psychiatry; 1983 Jun; 18(6):635-49. PubMed ID: 6191784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxanthine, xanthine, urate and creatinine concentration gradients in cerebrospinal fluid.
    Niklasson F; Hetta J; Degrell I
    Ups J Med Sci; 1988; 93(3):225-32. PubMed ID: 3238822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in cerebrospinal fluid uridine, hypoxanthine, and xanthine in head-injured patients.
    Mueller RA; Rosner MJ; Ghia JN; Powers SK; Kafer ER; Hunt RD
    Cell Mol Neurobiol; 1988 Jun; 8(2):235-43. PubMed ID: 3409270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid calcium, parathyroid hormone, and monoamine and purine metabolites and the blood-brain barrier function in primary hyperparathyroidism.
    Joborn C; Hetta J; Niklasson F; Rastad J; Wide L; Agren H; Akerström G; Ljunghall S
    Psychoneuroendocrinology; 1991; 16(4):311-22. PubMed ID: 1720895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased concentration of hypoxanthine in human central cerebrospinal fluid after subarachnoid haemorrhage.
    von Holst H; Sollevi A
    Acta Neurochir (Wien); 1985; 77(1-2):52-9. PubMed ID: 4036678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPLC method for measurement of purine nucleotide degradation products in cerebrospinal fluid.
    Kuracka L; Kalnovicová T; Líska B; Turcáni P
    Clin Chem; 1996 May; 42(5):756-60. PubMed ID: 8653903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid hypoxanthine and xanthine concentrations as indicators of metabolic damage due to raised intracranial pressure in hydrocephalic children.
    Levin SD; Brown JK; Harkness RA
    J Neurol Neurosurg Psychiatry; 1984 Jul; 47(7):730-3. PubMed ID: 6747648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid nucleotide metabolites following non-convulsive status epilepticus.
    Livingston JH; Brown JK; Harkness RA; McCreanor GM
    Dev Med Child Neurol; 1989 Apr; 31(2):168-73. PubMed ID: 2737369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Purine transport through the blood-brain barrier in hypoxanthine phosphoribosyltransferase deficiency].
    López Jiménez M; García Puig J; Mateos Antón F; Ramos Hernández T; Pascual Castroviejo I; Ortiz Vázquez J
    Med Clin (Barc); 1989 Feb; 92(5):167-70. PubMed ID: 2725104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The concentrations of xanthine and hypoxanthine in cerebrospinal fluid as therapeutic guides in hydrocephalus.
    Castro-Gago M; Lojo S; Del Rio R; Rodriguez A; Novo I; Rodriguez-Segade S
    Childs Nerv Syst; 1986; 2(3):109-11. PubMed ID: 3779664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain energy metabolism and blood-brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood.
    Niklasson F; Agren H
    Biol Psychiatry; 1984 Aug; 19(8):1183-206. PubMed ID: 6498242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low levels of somatostatin in human CSF mark depressive episodes.
    Agren H; Lundqvist G
    Psychoneuroendocrinology; 1984; 9(3):233-48. PubMed ID: 6149588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid nucleotide metabolites following short febrile convulsions.
    Livingston JH; Brown JK; Harkness RA; McCreanor GM; O'Hare AE
    Dev Med Child Neurol; 1989 Apr; 31(2):161-7. PubMed ID: 2737368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration of purine compounds in the cerebrospinal fluid of infants suffering from sepsis, convulsions and hydrocephalus.
    Schmidt H; Siems WG; Grune T; Grauel EL
    J Perinat Med; 1995; 23(3):167-74. PubMed ID: 8568608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric acid, xanthine and hypoxanthine in the cerebrospinal fluid.
    PRAETORIUS E; POULSEN H; DUPONT H
    Scand J Clin Lab Invest; 1957; 9(2):133-7. PubMed ID: 13442566
    [No Abstract]   [Full Text] [Related]  

  • 18. Post-mortem oxypurine concentrations in the CSF.
    Manzke H; Krämer M; Dörner K
    Adv Exp Med Biol; 1986; 195 Pt A():587-91. PubMed ID: 3728185
    [No Abstract]   [Full Text] [Related]  

  • 19. CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa.
    Gerner RH; Hare TA
    Am J Psychiatry; 1981 Aug; 138(8):1098-101. PubMed ID: 7258390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabolism of purine nucleotides in the central nervous system in patients with phosphoribosylpyrophosphate synthetase hyperactivity and neurosensory deafness].
    López Jiménez M; García Puig J; Mateos Antón F; Ramos Hernández T; Sebastián Melián J; García Neito V
    Neurologia; 1990 Jan; 5(1):14-7. PubMed ID: 2163266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.